Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Jun 15, 2024; 16(6): 2673-2682
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2673
Published online Jun 15, 2024. doi: 10.4251/wjgo.v16.i6.2673
Table 2 Distribution of KRAS, NRAS, PIK3CA, and BRAF mutations in patients with colorectal carcinoma, n (%)
| Mutation genes | All patients (n = 2271) | Mucinous adenocarcinoma (n = 113) |
| KRAS | ||
| Exon 2 | 653 (28.8) | 42 (37.2) |
| Exon 3 | 34 (1.5) | 3 (2.7) |
| Exon 4 | 48 (2.1) | 5 (4.4) |
| Exon 2/3 | 3 (0.1) | 0 |
| Exon 2/4 | 3 (0.1) | 0 |
| NRAS | ||
| Exon 2 | 33 (1.5) | 0 |
| Exon 3 | 25 (1.1) | 0 |
| BRAF | ||
| Exon 15 | 85 (3.7) | 14 (12.4) |
| PIK3CA | ||
| Exon 20 | 88 (3.9) | 8 (7.1) |
- Citation: Chen H, Jiang RY, Hua Z, Wang XW, Shi XL, Wang Y, Feng QQ, Luo J, Ning W, Shi YF, Zhang DK, Wang B, Jie JZ, Zhong DR. Comprehensive analysis of gene mutations and mismatch repair in Chinese colorectal cancer patients. World J Gastrointest Oncol 2024; 16(6): 2673-2682
- URL: https://www.wjgnet.com/1948-5204/full/v16/i6/2673.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i6.2673